Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial.

Vaccine·2013
Same author

[Clinical evaluation of the new coat colour macchiato in a male Franches-Montagnes horse].

Schweizer Archiv fur Tierheilkunde·2013
Same author

Treatment of cows with milk fever using intravenous and oral calcium and phosphorus.

Schweizer Archiv fur Tierheilkunde·2012
Same author

[The effect of oral calcium lactate in postpartum cows].

Schweizer Archiv fur Tierheilkunde·2012
Same author

High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease.

BMC infectious diseases·2011
Same author

Usefulness of double locus sequence typing (DLST) for regional and international epidemiological surveillance of methicilin-resistant Staphylococcus aureus.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2009

Related Experiment Video

Updated: Jul 6, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Endocarditis prophylaxis: from experimental models to human recommendation

M Blatter1, P Francioli

  • 1Division des Maladies Infectieuses, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

European Heart Journal
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Antibiotic prophylaxis for endocarditis is effective when it inhibits bacterial growth on heart valves. The duration of antibiotic action needed depends on the initial bacterial load for successful prevention.

More Related Videos

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

A Hypoxia-Reoxygenation Injury Model in Self-Assembling Human Cardioids
10:41

A Hypoxia-Reoxygenation Injury Model in Self-Assembling Human Cardioids

Published on: March 17, 2026

Related Experiment Videos

Last Updated: Jul 6, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

A Hypoxia-Reoxygenation Injury Model in Self-Assembling Human Cardioids
10:41

A Hypoxia-Reoxygenation Injury Model in Self-Assembling Human Cardioids

Published on: March 17, 2026

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Cardiology

Background:

  • Bacterial adherence to damaged heart valves is a key event in endocarditis development.
  • Host defense mechanisms and bacterial inoculum size influence endocarditis progression.
  • Animal models are crucial for understanding antibiotic efficacy in endocarditis prophylaxis.

Purpose of the Study:

  • To elucidate the role of antibiotic prophylaxis in preventing endocarditis.
  • To determine the relationship between antibiotic duration and bacterial load in prophylaxis.
  • To provide an evidence-based rationale for endocarditis prophylaxis guidelines.

Main Methods:

  • Utilizing animal models to simulate bacterial adherence to cardiac valves during bacteremia.
  • Assessing the impact of antibiotic presence and duration on bacterial growth and host defense.
  • Correlating experimental findings with clinical recommendations for prophylaxis.

Main Results:

  • Antibiotics inhibit bacterial growth on adhered microorganisms, allowing host defenses to act.
  • Short-term antibiotic prophylaxis (6 hours) is effective for low bacterial inoculums.
  • Higher bacterial loads necessitate longer durations of antibiotic inhibitory activity for successful prophylaxis.

Conclusions:

  • Antibiotic prophylaxis duration should be tailored to the anticipated bacterial burden.
  • Experimental data support specific recommendations for human endocarditis prophylaxis.
  • Understanding bacterial adherence and antibiotic action is key to effective prevention strategies.